Acute ischaemic stroke: recent advances in reperfusion treatment
Jazyk angličtina Země Velká Británie, Anglie Médium print
Typ dokumentu přehledy, časopisecké články, práce podpořená grantem
PubMed
36477996
PubMed Central
PMC10079392
DOI
10.1093/eurheartj/ehac684
PII: 6881118
Knihovny.cz E-zdroje
- Klíčová slova
- Acute stroke, Endovascular, Thrombectomy, Thrombolysis,
- MeSH
- cévní mozková příhoda * terapie komplikace MeSH
- endovaskulární výkony * metody MeSH
- ischemická cévní mozková příhoda * komplikace MeSH
- ischemie mozku * terapie komplikace MeSH
- lidé MeSH
- prospektivní studie MeSH
- reperfuze škodlivé účinky MeSH
- stenty škodlivé účinky MeSH
- trombektomie metody MeSH
- výsledek terapie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
During the last 5-7 years, tremendous progress was achieved in the reperfusion treatment of acute ischaemic stroke during its first few hours from symptom onset. This review summarizes the latest evidence from randomized clinical trials and prospective registries with a focus on endovascular treatment using stent retrievers, aspiration catheters, thrombolytics, and (in selected patients) carotid stenting. Novel approaches in prehospital (mobile interventional stroke teams) and early hospital (direct transfer to angiography) management are described, and future perspectives ('all-in-one' laboratories with angiography and computed tomography integrated) are discussed. There is reasonable chance for patients with moderate-to-severe acute ischaemic stroke to survive without permanent sequelae when the large-vessel occlusion is removed by means of modern pharmaco-mechanic approach. Catheter thrombectomy is now the golden standard of acute stroke treatment. The role of cardiologists in stroke is expanding from diagnostic help (to reveal the cause of stroke) to acute therapy in those regions where such up-to-date Class I. A treatment is not yet available.
Zobrazit více v PubMed
Wagner A, Schebesch KM, Isenmann S, Steinbrecher A, Kapapa T, Zeman F, et al. Interdisciplinary decision making in hemorrhagic stroke based on CT imaging—differences between neurologists and neurosurgeons regarding estimation of patients’ symptoms, Glasgow Coma Scale, and National Institutes of Health Stroke Scale. Front Neurol 2019;10:997. 10.3389/fneur.2019.00997 PubMed DOI PMC
Manners J, Khandker N, Barron A, Aziz Y, Desai SM, Morrow B, et al. An interdisciplinary approach to inhospital stroke improves stroke detection and treatment time. J Neurointerv Surg 2019;11:1080–1084. 10.1136/neurintsurg-2019-014890 PubMed DOI
Widimsky P, Doehner W, Diener HC, Van Gelder IC, Halliday A, Mazighi M, et al. The role of cardiologists in stroke prevention and treatment: position paper of the European Society of Cardiology Council on Stroke. Eur Heart J 2018;39:1567–1573. 10.1093/eurheartj/ehx478 PubMed DOI
Lip GYH, Lane DA, Lenarczyk R, Boriani G, Doehner W, Benjamin LA, et al. Integrated care for optimizing the management of stroke and associated heart disease: a position paper of the European Society of Cardiology Council on Stroke. Eur Heart J 2022;43:2442–2460. 10.1093/eurheartj/ehac245 PubMed DOI PMC
Nardai S, Lanzer P, Abelson M, Baumbach A, Doehner W, Hopkins LN, et al. Interdisciplinary management of acute ischaemic stroke: current evidence training requirements for endovascular stroke treatment: position paper from the ESC Council on Stroke and the European Association for Percutaneous Cardiovascular Interventions with the support of the European Board of Neurointervention. Eur Heart J 2021;42:298–307. 10.1093/eurheartj/ehaa833 PubMed DOI
Nogueira RG, Jadhav AP, Haussen DC, Bonafe A, Budzik RF, Bhuva P, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med 2018;378:11–21. 10.1056/NEJMoa1706442 PubMed DOI
Saver JL, Goyal M, van der Lugt A, Menon BK, Majoie CB, Dippel DW, et al. Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis. JAMA 2016;316:1279–1288. 10.1001/jama.2016.13647 PubMed DOI
Cash RE, Boggs KM, Richards CT, Camargo CA Jr, Zachrison KS. Emergency medical service time intervals for patients with suspected stroke in the United States. Stroke 2022;53:e75–e78. 10.1161/STROKEAHA.121.037509 PubMed DOI
Choi PMC, Tsoi AH, Pope AL, Leung S, Frost T, Loh PS, et al. Door-in-door-out time of 60 minutes for stroke with emergent large vessel occlusion at a primary stroke center. Stroke 2019;50:2829–2834. 10.1161/STROKEAHA.119.025838 PubMed DOI
McTaggart RA, Moldovan K, Oliver LA, Dibiasio EL, Baird GL, Hemendinger ML, et al. Door-in-door-out time at primary stroke centers may predict outcome for emergent large vessel occlusion patients. Stroke 2018;49:2969–2974. 10.1161/STROKEAHA.118.021936 PubMed DOI
Morey JR, Zhang X, Marayati NF, Matsoukas S, Fiano E, Oxley T, et al. Mobile interventional stroke teams improve outcomes in the early time window for large vessel occlusion stroke. Stroke 2021;52:e527–e530. 10.1161/STROKEAHA.121.034222 PubMed DOI
Widimsky P, Asil T, Abelson M, Koznar B, Tasal A, Roos J, et al. Direct catheter-based thrombectomy for acute ischemic stroke: outcomes of consecutive patients treated in interventional cardiology centers in close cooperation with neurologists. J. Am Coll Cardiol 2015;66:487–488. 10.1016/j.jacc.2015.04.076 PubMed DOI
Requena M, Ren Z, Ribo M. Direct transfer to angiosuite in acute stroke: why, when, and how? Neurology 2021;97:S34–S41. 10.1212/WNL.0000000000012799 PubMed DOI
Requena M, Olivé-Gadea M, Muchada M, Hernández D, Rubiera M, Boned S, et al. Direct to angiography suite without stopping for computed tomography imaging for patients with acute stroke: a randomized clinical trial. JAMA Neurol 2021;78:1099–1107. 10.1001/jamaneurol.2021.2385 PubMed DOI PMC
Jovin TG, Nogueira RG, Lansberg MG, Demchuk AM, Martins SO, Mocco J, et al. Thrombectomy for anterior circulation stroke beyond 6 h from time last known well (AURORA): a systematic review and individual patient data meta-analysis. Lancet 2022;399:249–258. 10.1016/S0140-6736(21)01341-6 PubMed DOI
Nogueira RG, Haussen DC, Liebeskind DS, Jovin TG, Gupta R, Saver JL, et al. Clinical effectiveness of endovascular stroke treatment in the early and extended time windows. Int J Stroke 2022;17:389–399. 10.1177/17474930211005740 PubMed DOI
Mori E, Yoneda Y, Tabuchi M, Yoshida T, Ohkawa S, Ohsumi Y, et al. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology 1992;42:976–982. 10.1212/WNL.42.5.976 PubMed DOI
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group . Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581–1587. PubMed
Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010;375:1695–1703. 10.1016/S0140-6736(10)60491-6 PubMed DOI
Ma H, Campbell BCV, Parsons MW, Churilov L, Levi CR, Hsu C, et al. Thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke. N Engl J Med 2019;380:1795–1803. 10.1056/NEJMoa1813046 PubMed DOI
Lim JC, Churilov L, Bivard A, Ma H, Dowling RJ, Campbell BCV, et al. Does intravenous thrombolysis within 4.5 to 9 hours increase clot migration leading to endovascular inaccessibility? Stroke 2021;52:1083–1086. 10.1161/STROKEAHA.120.030661 PubMed DOI
Reiff T, Barthel O, Ringleb PA, Pfaff J, Mundiyanapurath S. Safety of mechanical thrombectomy with combined intravenous thrombolysis in stroke treatment 4.5 to 9 hours from symptom onset. J Stroke Cerebrovasc Dis 2020;29:105204. 10.1016/j.jstrokecerebrovasdis.2020.105204 PubMed DOI
Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA 1999;282:2003–2011. 10.1001/jama.282.21.2003 PubMed DOI
Khatri P, Hill MD, Palesch YY, Spilker J, Jauch EC, Carrozzella JA, et al. Methodology of the interventional management of stroke III trial. Int J Stroke 2008;3:130–137. 10.1111/j.1747-4949.2008.00151.x PubMed DOI PMC
Renú A, Millán M, San Román L, Blasco J, Martí-Fŕbregas J, Terceńo M, et al. Effect of intra-arterial alteplase vs placebo following successful thrombectomy on functional outcomes in patients with large vessel occlusion acute ischemic stroke. The CHOICE randomized clinical trial. JAMA 2022;327:826–835. 10.1001/jama.2022.1645 PubMed DOI PMC
Zhou Y, Zhang L, Ospel J, Goyal M, McDonough R, Xing P, et al. Association of intravenous alteplase, early reperfusion, and clinical outcome in patients with large vessel occlusion stroke: post hoc analysis of the randomized DIRECT-MT trial. Stroke 2022;53:1828–1836. 10.1161/STROKEAHA.121.037061 PubMed DOI
LeCouffe NE, Kappelhof M, Treurniet KM, Rinkel LA, Bruggeman AE, Berkhemer OA, et al. A randomized trial of intravenous alteplase before endovascular treatment for stroke. N Engl J Med 2021;385:1833–1844. 10.1056/NEJMoa2107727 PubMed DOI
Suzuki K, Matsumaru Y, Takeuchi M, Morimoto M, Kanazawa R, et al. Effect of mechanical thrombectomy without vs with intravenous thrombolysis on functional outcome among patients with acute ischemic stroke. The SKIP randomized clinical trial. JAMA 2021;325:244–253. 10.1001/jama.2020.23522 PubMed DOI PMC
Campbell BCV, Mitchell PJ, Churilov L, Yassi N, Kleinig TJ, Dowling RJ, et al. Tenecteplase versus alteplase before thrombectomy for ischemic stroke. N Engl J Med 2018;378:1573–1582. 10.1056/NEJMoa1716405 PubMed DOI
Berkhemer OA, Fransen PSS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372:11–20. 10.1056/NEJMoa1411587 PubMed DOI
Campbell BCV, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, et al. Endovascular therapy for ischemic stroke with per- fusion-imaging selection. N Engl J Med 2015;372:1009–1018. 10.1056/NEJMoa1414792 PubMed DOI
Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thorn- ton J, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 2015;372:1019–1030. 10.1056/NEJMoa1414905 PubMed DOI
Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med 2015;372:2296–2306. 10.1056/NEJMoa1503780 PubMed DOI
Saver JL, Goyal M, Bonafe A, Diener H-C, Levy EI, Pereira VM, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 2015;372:2285–2295. 10.1056/NEJMoa1415061 PubMed DOI
Goyal M, Menon BK, van Zwam WH, Dippel DWJ, Mitchell PJ, Demchuk AM, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 2016;387:1723–1731. 10.1016/S0140-6736(16)00163-X PubMed DOI
Albers GW, Marks MP, Kemp S, Christensen S, Tsai JP, Ortega-Gutierrez S, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med 2018;378:708–718. 10.1056/NEJMoa1713973 PubMed DOI PMC
Sarraj A, Hassan AE, Savitz S, Sitton C, Grotta J, Chen P, et al. Outcomes of endovascular thrombectomy vs medical management alone in patients with large ischemic cores: a secondary analysis of the optimizing patient’s selection for endovascular treatment in acute ischemic stroke (SELECT) study. JAMA Neurol 2019;76:1147–1156. 10.1001/jamaneurol.2019.2109 PubMed DOI PMC
Yoshimura S, Sakai N, Yamagami H, Uchida K, Beppu M, Toyoda K, et al. Endovascular therapy for acute stroke with a large ischemic region. N Engl J Med 2022;386:1303–1313. 10.1056/NEJMoa2118191 PubMed DOI
Perianen PP, Yan B. Are we ready to offer endovascular thrombectomy to all patients with large ischemic core? Front Neurol 2022;13:893975. 10.3389/fneur.2022.893975 PubMed DOI PMC
Sarraj A, Hassan A, Savitz SI, Grotta JC, Cai C, Parsha KN, et al. Endovascular thrombectomy for mild strokes: how low should we go? Stroke 2018;49:2398–2405. 10.1161/STROKEAHA.118.022114 PubMed DOI PMC
Goyal N, Tsivgoulis G, Malhotra K, Ishfaq MF, Pandhi A, Frohler MT, et al. Medical management vs mechanical thrombectomy for mild strokes: an international multicenter study and systematic review and meta-analysis. JAMA Neurol 2020;77:16–24. 10.1001/jamaneurol.2019.3112 PubMed DOI PMC
Seners P, Ben Hassen W, Lapergue B, Arquizan C, Heldner MR, Henon H, et al. Prediction of early neurological deterioration in individuals with Minor stroke and large vessel occlusion intended for intravenous thrombolysis alone. JAMA Neurol 2021;78:321–328. 10.1001/jamaneurol.2020.4557 PubMed DOI PMC
Zaidat OO, Mueller-Kronast NH, Hassan AE, Haussen DC, Jadhav AP, Froehler MT, et al. Impact of balloon guide catheter use on clinical and angiographic outcomes in the STRATIS stroke thrombectomy registry. Stroke 2019;50:697–704. 10.1161/STROKEAHA.118.021126 PubMed DOI
Brinjikji W, Starke RM, Murad MH, Fiorella D, Pereira VM, Goyal M, et al. Impact of balloon guide catheter on technical and clinical outcomes: a systematic review and meta-analysis. J Neurointerv Surg 2018;10:335–339. 10.1136/neurintsurg-2017-013179 PubMed DOI
Lapergue B, Blanc R, Gory B, Labreuche J, Duhamel A, Marnat G, et al. Effect of endovascular contact aspiration vs stent retriever on revascularization in patients with acute ischemic stroke and large vessel occlusion: the aster randomized clinical trial. JAMA 2017;318:443–452. 10.1001/jama.2017.9644 PubMed DOI PMC
Nogueira RG, Frei D, Kirmani JF, Zaidat O, Lopes D, Turk AS III, et al. Safety and efficacy of a:3. -dimensional stent retriever with aspiration-based thrombectomy vs aspiration-based thrombectomy alone in acute ischemic stroke intervention: a randomized clinical trial. JAMA Neurol 2018;75:304–311. 10.1001/jamaneurol.2017.3967 PubMed DOI PMC
Turk AS III, Siddiqui A, Fifi JT, De Leacy RA, Fiorella DJ, Gu E, , et al. Aspiration thrombectomy versus stent retriever thrombectomy as first-line approach for large vessel occlusion (compass): a multicentre, randomised, open label, blinded outcome, non-inferiority trial. Lancet 2019;393:998–1008. 10.1016/S0140-6736(19)30297-1 PubMed DOI
Mohammaden MH, Haussen DC, Perry da Camara C, Pisani L, Olive Gadea M, Al-Bayati AR, et al. Hyperdense vessel sign as a potential guide for the choice of stent retriever versus contact aspiration as first-line thrombectomy strategy. J Neurointerv Surg 2021;13:599–604. 10.1136/neurintsurg-2020-016005 PubMed DOI
Bourcier R, Mazighi M, Labreuche J, Fahed R, Blanc R, Gory B, et al. Susceptibility vessel sign in the aster trial: higher recanalization rate and more favourable clinical out- come after first line stent retriever compared to contact aspiration. J Stroke 2018;20:268–276. 10.5853/jos.2018.00192 PubMed DOI PMC
Langezaal LCM, van der Hoeven EJRJ, Mont’Alverne FJA, de Carvalho JJF, Lima FO, Dippel DWJ, et al. Endovascular therapy for stroke due to basilar-artery occlusion. N Engl J Med 2021;384:1910–1920. 10.1056/NEJMoa2030297 PubMed DOI
Liu X, Dai Q, Ye R, Zi W, Liu Y, Wang H, et al. Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. Lancet Neurol 2020;19:115–122. 10.1016/S1474-4422(19)30395-3 PubMed DOI
Tao C, Nogueira RG, Zhu Y, Sun J, Han H, Yuan G, et al. Trial of endovascular treatment of acute basilar-artery occlusion. N Engl J Med 2022; 387:1361–1372. 10.1056/NEJMoa2206317 PubMed DOI
Da Ros V, Scaggiante J, Pitocchi F, Sallustio F, Lattanzi S, Umana GE, et al. Mechanical thrombectomy in acute ischemic stroke with tandem occlusions: impact of extracranial carotid lesion etiology on endovascular management and outcome. Neurosurg Focus 2021;51:E6. 10.3171/2021.4.FOCUS21111 PubMed DOI
Haussen DC, Turjman F, Piotin M, Labreuche J, Steglich-Arnholm H, Holtmannspötter M, et al. Head or neck first? Speed and rates of reperfusion in thrombectomy for tandem large vessel occlusion strokes. Interv Neurol 2020; 8:92–100. 10.1159/000496292 PubMed DOI PMC
Zinkstok SM, Roos YB. Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: a randomised controlled trial. Lancet 2012;380:731–737. 10.1016/S0140-6736(12)60949-0 PubMed DOI
Papanagiotou P, Haussen DC, Turjman F, Labreuche J, Piotin M, Kastrup A, et al. Carotid stenting with antithrombotic agents and intracranial thrombectomy leads to the highest recanalization rate in patients with acute stroke with tandem lesions. JACC Cardiovasc Interv 2018;11:1290–1299. 10.1016/j.jcin.2018.05.036 PubMed DOI
Gory B, Haussen DC, Piotin M, Steglich-Arnholm H, Holtmannspötter M, Labreuche J, et al. Impact of intravenous thrombolysis and emergent carotid stenting on reperfusion and clinical outcomes in patients with acute stroke with tandem lesion treated with thrombectomy: a collaborative pooled analysis. Eur J Neurol 2018;25:1115–1120. 10.1111/ene.13633 PubMed DOI
Sadeh-Gonik U, Tau N, Friehmann T, Bracard S, Anxionnat R, Derelle AL, et al. Thrombectomy outcomes for acute stroke patients with anterior circulation tandem lesions: a clinical registry and an update of a systematic review with meta-analysis. Eur J Neurol 2018;25:693–700. 10.1111/ene.13577 PubMed DOI
Stampfl S, Ringleb PA, Möhlenbruch M, Hametner C, Herweh C, Pham M, et al. Emergency cervical internal carotid artery stenting in combination with intracranial thrombectomy in acute stroke. Am J Neuroradiol 2014;35:741–746. 10.3174/ajnr.A3763 PubMed DOI PMC
Menon BK, Hill MD, Davalos A, Roos YBWEM, Campbell BCV, Dippel DWJ, et al. Efficacy of endovascular thrombectomy in patients with M2 segment middle cerebral artery occlusions: meta-analysis of data from the HERMES collaboration. J Neurointerv Surg 2019;11:1065–1069. 10.1136/neurintsurg-2018-014678 PubMed DOI
Grossberg JA, Rebello LC, Haussen DC, Bouslama M, Bowen M, Barreira CM, et al. Beyond large vessel occlusion strokes: distal occlusion thrombectomy. Stroke 2018;49:1662–1668. 10.1161/STROKEAHA.118.020567 PubMed DOI
Sandercock PA, Counsell C, Kane EJ. Anticoagulants for acute ischaemic stroke. Cochrane Database Syst Rev. 2015;2015(3):CD000024. 10.1002/14651858.CD000024.pub4 PubMed DOI PMC
Yang M, Huo X, Gao F, Wang A, Ma N, Liebeskind DS, et al. Safety and efficacy of heparinization during mechanical thrombectomy in acute ischemic stroke. Front Neurol 2019;10:299. 10.3389/fneur.2019.00299 PubMed DOI PMC
Chalos V, van de Graaf RA, Roozenbeek B, van Es ACGM, den Hertog HM, Staals J, et al. Multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke. The effect of periprocedural medication: acetylsalicylic acid, unfractionated heparin, both, or neither (MR CLEAN-MED). Rationale and study design. Trials 2020;21:644. 10.1186/s13063-020-04514-9 PubMed DOI PMC
Simonsen CZ, Yoo AJ, Sørensen LH, Juul N, Johnsen SP, Andersen G, et al. Effect of general anesthesia and conscious sedation during endovascular therapy on infarct growth and clinical outcomes in acute ischemic stroke. JAMA Neurol 2018;75:470–477. 10.1001/jamaneurol.2017.4474 PubMed DOI PMC
Cappellari M, Pracucci G, Forlivesi S, Saia V, Nappini S, Nencini P, et al. General anesthesia versus conscious sedation and local anesthesia during thrombectomy for acute ischemic stroke. Stroke 2020;51:2036–2044. 10.1161/STROKEAHA.120.028963 PubMed DOI
Matusevicius M, Cooray C, Bottai M, Mazya M, Tsivgoulis G, Nunes AP, et al. Blood pressure after endovascular thrombectomy: modelling for outcomes based on recanalization status. Stroke 2020;51:519–525. 10.1161/STROKEAHA.119.026914 PubMed DOI
Bath PM, Song L, Silva GS, Mistry E, Petersen N, Tsivgoulis G, et al. Blood pressure management for ischemic stroke in the first 24 hours. Stroke 2022;53:1074–1084. 10.1161/STROKEAHA.121.036143 PubMed DOI PMC
Sun D, Huo X, Raynald JB, Tong X, Ma G, et al. Predictors of symptomatic intracranial hemorrhage after endovascular treatment for acute large vessel occlusion: data from ANGEL-ACT registry. J Thromb Thrombolysis 2022;54:558–565. 10.1007/s11239-022-02688-4 PubMed DOI
Neutrophil Extracellular Traps and Thrombolysis Resistance: New Insights for Targeting Therapies
The importance of interdisciplinary research